Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | Director | May 13, 2022 | May 17, 2022 |
| Stevanato Group S.p.A.STVN · Entity 3826 | Director | June 12, 2026 | June 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date May 13, 2022 · Filed May 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 55,753 |
Reported balance
After 2022-05-13 transaction · row 1
1 source rowRow 1 · 2022-05-13 · Grant · Acquired 3,456 · Balance 55,753 |
Stevanato Group S.p.A.
Report date June 12, 2026 · Filed June 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 37,424 |
Ending reported balance
After 2026-06-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-12 · Grant · Acquired 4,975 · Balance 38,917 F1: Represents ordinary shares granted as equity compensation in connection with the Reporting Person's service as director. Row 2 · 2026-06-15 · Sale · Disposed 1,493 · Balance 37,424 F2: Represents ordinary shares sold by the Reporting Person to cover tax obligations associated with the grant of ordinary shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents ordinary shares granted as equity compensation in connection with the Reporting Person's service as director.
F2: Represents ordinary shares sold by the Reporting Person to cover tax obligations associated with the grant of ordinary shares.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Catalent, Inc.
Report date December 18, 2024 · Filed December 18, 2024
Section 16 reporting ended · disclosed 2024-12-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-12-18 transaction · row 1
1 source rowRow 1 · 2024-12-18 · Disposition to issuer · Disposed 70,118 · Balance 0 F1: On December 18, 2024, Creek Parent, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), dated as of February 5, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F2: Includes restricted stock units ("RSUs"). F3: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $63.50 in cash, without interest (the "Merger Consideration"). F4: At the Effective Time, each RSU, whether or not vested, outstanding immediately prior to the Effective Time vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer common stock subject to the RSU multiplied by (ii) the Merger Consideration, except for certain RSUs granted following the date of the Merger Agreement which were converted at the Effective Time into restricted cash awards equal to the product of (a) the Merger Consideration multiplied by (b) the number of shares of Issuer common stock subject to such award and otherwise remain subject to their terms, including vesting and acceleration terms. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 18, 2024, Creek Parent, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), dated as of February 5, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger").
F2: Includes restricted stock units ("RSUs").
F3: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $63.50 in cash, without interest (the "Merger Consideration").
F4: At the Effective Time, each RSU, whether or not vested, outstanding immediately prior to the Effective Time vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer common stock subject to the RSU multiplied by (ii) the Merger Consideration, except for certain RSUs granted following the date of the Merger Agreement which were converted at the Effective Time into restricted cash awards equal to the product of (a) the Merger Consideration multiplied by (b) the number of shares of Issuer common stock subject to such award and otherwise remain subject to their terms, including vesting and acceleration terms.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2026 Filed Jun 26, 2026 10:12 UTC | Stevanato Group S.p.A. STVN · Entity 3826 | SaleOrdinary Shares | 1,493 | $17.09 | $25,515.37 |
DisclosureSEC source: 0001193125-26-283809 · ownership.xml · nonDerivative · entry 2 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,424 F2 · shares: Represents ordinary shares sold by the Reporting Person to cover tax obligations associated with the grant of ordinary shares. Read SEC document |
| June 12, 2026 Filed Jun 26, 2026 10:12 UTC | Stevanato Group S.p.A. STVN · Entity 3826 | GrantOrdinary Shares | 4,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-283809 · ownership.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,917 F1 · shares: Represents ordinary shares granted as equity compensation in connection with the Reporting Person's service as director. Read SEC document |
| December 18, 2024 Filed Dec 18, 2024 18:06 UTC | Catalent, Inc. CTLT · Entity 16279 | Disposition to issuerCommon Stock | 70,118 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-137723 · ownership.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: On December 18, 2024, Creek Parent, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), dated as of February 5, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F2 · shares: Includes restricted stock units ("RSUs"). F3 · price: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $63.50 in cash, without interest (the "Merger Consideration"). F4 · price: At the Effective Time, each RSU, whether or not vested, outstanding immediately prior to the Effective Time vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer common stock subject to the RSU multiplied by (ii) the Merger Consideration, except for certain RSUs granted following the date of the Merger Agreement which were converted at the Effective Time into restricted cash awards equal to the product of (a) the Merger Consideration multiplied by (b) the number of shares of Issuer common stock subject to such award and otherwise remain subject to their terms, including vesting and acceleration terms. Read SEC document |
| October 30, 2024 Filed Nov 1, 2024 21:07 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 4,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-24-000103 · wk-form4_1730495269.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,118 F1 · shares: The equity acquired by the reporting person is the annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation program. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of (i) a "change in control" (as defined in the Catalent, Inc. 2018 Omnibus Incentive Plan) and (ii) one year from the date of award, subject to continued service. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 27, 2023 Filed Oct 31, 2023 20:27 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 6,993 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-23-000143 · wk-form4_1698784039.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,455 F1 · shares: The equity acquired by the reporting person is the annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation program. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award, subject to continued service. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 27, 2022 Filed Oct 31, 2022 21:10 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 4,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-22-000177 · wf-form4_166725062281570.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,462 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of one year from the date of award and the date of the Issuer's fiscal 2023 annual meeting of shareholders. F2 · balance_after: Includes restricted stock units. Read SEC document |
| May 13, 2022 Filed May 17, 2022 20:47 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,456 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029714 · doc4.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,753 Read SEC document |
| October 28, 2021 Filed Nov 1, 2021 12:01 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-21-000175 · wf-form4_163576807063550.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,313 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of one year from the date of award and the date of the Issuer's fiscal 2022 annual meeting of shareholders. F2 · balance_after: Includes restricted stock units. Read SEC document |
| May 14, 2021 Filed May 17, 2021 20:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,896 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033163 · doc4.xml · nonDerivative · entry 2 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,297 Read SEC document |
| May 14, 2021 Filed May 17, 2021 20:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 530 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033163 · doc4.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,401 Read SEC document |
| October 29, 2020 Filed Nov 2, 2020 12:21 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 2,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-20-000216 · wf-form4_160431970297727.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,911 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of one year from the date of award and the date of the Issuer's fiscal 2021 annual meeting of shareholders. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 22:47 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 661 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-20-000146 · wf-form4_159865485639998.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,786 F1 · kind: The equity acquired by the reporting person is part of the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. The grant is in respect of the period between July 1, 2020 and the date of the reporting person's annual meeting of shareholders in respect of fiscal 2020. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:05 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 4,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029704 · doc4.xml · nonDerivative · entry 2 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,871 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:05 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029704 · doc4.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,653 F1 · balance_after: This total corrects the total number of shares beneficially owned due to a clerical error in the Reporting Person's Form 4 previously filed on May 20, 2019. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 19:50 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 3,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-19-000165 · wf-form4_156684901914661.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,125 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| May 16, 2019 Filed May 20, 2019 22:34 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031528 · doc4.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,682 Read SEC document |
| May 15, 2019 Filed May 16, 2019 23:51 UTC | Catalent, Inc. CTLT · Entity 16279 | PurchaseCommon Stock | 10,000 | $44.44 | $444,400.00 |
DisclosureSEC source: 0001596783-19-000044 · wf-form4_155805069054425.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,958 F1 · price: Volume-weighted average price. These shares were purchased in multiple transactions at prices ranging from $43.99 to $44.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
| September 13, 2018 Filed Sep 17, 2018 14:56 UTC | Catalent, Inc. CTLT · Entity 16279 | PurchaseCommon Stock | 10,000 | $43.00 | $430,000.00 |
DisclosureSEC source: 0001596783-18-000148 · wf-form4_153719617848344.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,958 F1 · price: Volume-weighted average price. These shares were purchased in multiple transactions at prices ranging from $42.97 to $43.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 18:54 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 4,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-18-000071 · wf-form4_153513683657806.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,958 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation program. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| May 17, 2018 Filed May 21, 2018 20:49 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-031914 · doc4.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,077 Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 15:31 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 3,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-17-000128 · wf-form4_150393427463644.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,775 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package adopted in 2014. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 04, 2017 Filed Aug 4, 2017 20:11 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | PurchaseCommon Stock | 7,500 | $49.23 | $369,225.00 |
DisclosureSEC source: 0001209191-17-047698 · doc4.xml · nonDerivative · entry 2 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,112 Read SEC document |
| August 03, 2017 Filed Aug 4, 2017 20:11 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | PurchaseCommon Stock | 2,500 | $49.29 | $123,232.50 |
DisclosureSEC source: 0001209191-17-047698 · doc4.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,612 F1 · price: The price shown above represents the weighted average price of the shares purchased. The range of sale prices was $49.26 to $49.34. Read SEC document |
| May 23, 2017 Filed May 25, 2017 20:38 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035429 · doc4.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,112 F1 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 21:42 UTC | Catalent, Inc. CTLT · Entity 16279 | PurchaseCommon Stock | 10,000 | $29.27 | $292,700.00 |
DisclosureSEC source: 0001596783-17-000023 · wf-form4_148728133275998.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,799 F1 · price: These shares were purchased in multiple transactions at prices ranging from $29.20 to $29.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.